Two Doses of China's Sinovac Inadequate Against Omicron, Hong Kong Study Suggests - The New York Times

1. Two Doses of China's Sinovac Inadequate Against Omicron, Hong Kong Study Suggests  The New York Times
2. China's Sinovac Vaccine Inadequate Against Omicron Variant, Study Finds  Bloomberg Quicktake: Now
3. China’s Sinovac offers inadequate protection against Omicron, study shows  Financial Times
4. Forum: Potential problem if Sinovac jab does not offer enough protection against Omicron  The Straits Times
5. Covid-19: Study reveals Hong Kong jabs are ‘inadequate’ against Omicron, as mainland remains off city’s high-risk list despite variant cases  Hong Kong Free Press
6. View Full Coverage on Google News

https://ift.tt/33Afoh9 https://ift.tt/2SeTG7d